Riot Platforms is shaking things up in the tech world. The company's CEO, Jason Les, recently shared some big plans. He said that Bitcoin mining is just a stepping stone. It's not the main goal. Instead, it's a way to build something bigger: data centers. Les explained that Bitcoin mining helps Rio
A man from Washington state, Taylor Taranto, recently got off with time served for a hoax threat near former President Barack Obama's home. This stunt happened two years ago and caused a huge law enforcement response, including a bomb squad and sniffer dogs. Taranto spent 22 months in a D. C. jail
Qualigen Therapeutics, a biotech company, made a surprising move. They teamed up with BitGo, a crypto firm, to manage their digital assets. This news sent their stock soaring over 60% after hours. So, why is a biotech company getting into crypto? Well, they want to diversify their investments. They
In the Mass Effect series, players take on the role of Commander Shepard, who must save the galaxy from the Reaper threat. One of the most important decisions players make is choosing their class. While there are many options, Biotics stand out as the most exciting and effective. Biotics are specia
Cyprus has been split for decades. The Green Line is a unique buffer zone. It's not like the ones in Korea or Syria. This zone has people living, working, and studying. It's a mix of tavernas, hotels, and even a university. The division started after Cyprus gained independence from Britain in 1960.
A big step has been taken in the fight against a serious heart condition in kids. A company is testing a new stem cell treatment called laromestrocel. This treatment is being studied to help children with hypoplastic left heart syndrome (HLHS), a rare and severe heart defect. The good news is that t
Doxorubicin, a powerful drug used to fight cancer, has a big problem. It can hurt the heart. This is a serious issue because many people who beat cancer end up with heart failure later. For a long time, scientists thought this heart damage was mainly due to stress and direct injury. But now, they're
Biotech stocks have had a rough time since their peak in early 2021. They didn't join the market's rebound in 2022, but this summer brought a change. These stocks are tricky because most of them are in the early stages of development. They often don't have earnings or steady revenue, relying instead
CDR404, a new type of cancer treatment, is making waves in the medical world. This treatment is designed to target specific cancer cells and activate the body's immune system to fight them. Recent studies have shown that CDR404 can trigger a strong immune response in patients with certain types of c
The American Seed Trade Association (ASTA) is stepping into a bigger role. They will now lead the charge for biotech crop technology. This shift happened because the Biotechnology Innovation Organization (BIO) decided to focus solely on health and biopharmaceuticals. A committee made up of BIO memb
